谷歌浏览器插件
订阅小程序
在清言上使用

Progression-free Survival and Safety at 3.5 Years of Follow-Up: Results from the Randomized Phase 3 PRIMA/ENGOT-OV26/GOG-3012 Trial of Niraparib Maintenance Treatment in Patients with Newly Diagnosed Ovarian Cancer – a Plain Language Summary

Future oncology (London, England)(2024)

引用 0|浏览27
暂无评分
关键词
Platinum-Sensitive Ovarian Cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要